3Tanoud LT,Zitrik R,Elias TA.Systenic sarcoidosis.In:Baum GL,wol-Insky E,eds.Textbook of Pulmonary Disease.5th ed. Boston:Little Brown company,1994.745-770.
4Peckham Ls,spiteri MA.Sarcoidosis.Postgrad Med J,1996,72(Suppl 1):s196-s200.
5Marc A.Judson,MD,FCCP;Bruce W.Thompson,PHD;David L.Rabin,MD,MPH;et al.The Diagnostic Pathway to Sarcoidosis.Chest,2003,123(2):406-412.
6Piera Fazzi MD,Paola sbragia MD,Stefano solfanelli BS,et al.Functional significance of the decrease attenuation sign on expiratory CT in pulmonary sarcoidosis.Chest,2001,119(4):1270-1274.
2Baughman RP, Teirstein AS, Judson MA, et al. A Case Control Etiolog- ic Study of Sarcoidosis(ACCESS) research group. Clinical characteris- tics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med,2001,164 : 1885-1889.
3Yamashita U, Kuroda E. Regulation of macrophage-derived chemokine ( MDC, CCL22 ) production. Crit Rev Immuno1,2002,22 : 105-114.
4Banfield G,Watanabe H, Scadding G, et al. CC chemokine receptor g (CCR4) in human allergen-induced late nasal responses. Allergy, 2010,65 : 1126-1133.
5Garlepp M J, Rose AH, Dench JE, et al. Clonal analysis of lung and blood T ceils in patients with sarcoidosis. Thorax, 1994,49:577-585.
6Wallace WA, Howie SE. Immunoreaetive interleukin 4 and interferon- gamma expression by type II alveolar epithelial ceils in interstitial lung disease. J Pathol, 1999,187:475-480.
7A merican Thoracic Society (ATS) , European Respiratory Society (ERS) ,World association of sarcoidosis and other granulomatous dis- orders(WASOG). Statement on sarcoidosis. Am J Respir Crit Care Med, 1999,160:736-755.
8Callejas-Rubio JL, L6pez-P6rez L, Ortego-Centeno N, et al. Tumor nec- rosis factor-alpha inhibitor treatment for sarcoidosis. Ther Clin Risk Manag,2008,4 : 1305-1313.
9Marques LJ, Zheng L, Poulakis N, et al. Pentoxifylline inhibits TNF-al- pha production from human alveolar macrophages Marques. Am J Re- spit Crit Care Med, 1999,159:508-511.
10Asano M, Kohanawa M, Minagawa T, et al. Reciprocal action of inter- feron-gamma and interleukin-4 promotes granulomatous inflammation induced by Rhodococcus aurantiacus in Mice. Immunology, 1996,88 : 394-399.
